Rongcan Biotech
荣灿生物
Rongcan Biotech
Biotech/Healthcare
Rongcan Biotech, founded in June 2020, develops and commercializes novel mRNA therapeutics. It has established an end-to-end R&D system covering mRNA sequence design and synthesis processes, lipid chemistry, LNP formulation development and scale-up, analytical method development and validation, and…
Latest round: Series A Extension (2025)
Source: ChinaBulls — chinabulls.com
Last updated 2025-09-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.